Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 6;10(11):907.
doi: 10.3390/diagnostics10110907.

Alagille Syndrome: Diagnostic Challenges and Advances in Management

Affiliations
Review

Alagille Syndrome: Diagnostic Challenges and Advances in Management

Mohammed D Ayoub et al. Diagnostics (Basel). .

Abstract

Alagille syndrome (ALGS) is a multisystem disease characterized by cholestasis and bile duct paucity on liver biopsy in addition to variable involvement of the heart, eyes, skeleton, face, kidneys, and vasculature. The identification of JAG1 and NOTCH2 as disease-causing genes has deepened our understanding of the molecular mechanisms underlying ALGS. However, the variable expressivity of the clinical phenotype and the lack of genotype-phenotype relationships creates significant diagnostic and therapeutic challenges. In this review, we provide a comprehensive overview of the clinical characteristics and management of ALGS, and the molecular basis of ALGS pathobiology. We further describe unique diagnostic considerations that pose challenges to clinicians and outline therapeutic concepts and treatment targets that may be available in the near future.

Keywords: Alagille syndrome; JAG1; NOTCH2; bile duct paucity; intestinal bile acid transporters.

PubMed Disclaimer

Conflict of interest statement

B.M.K. provides consultations for Mirium, Albireo, and Audentes. B.M.K. receives unrestricted educational grant funding from Mirium and Albireo. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Clinical features of alagille syndrome. (A) Characteristic facies with prominent forehead, hypertelorism, straight nose with a bulbous tip, and a pointed chin. Parental consent was obtained for use of this photograph. (B) Cutaneous xanthoma of the palmar surface of the hand. (C) Xanthoma on the elbow.

References

    1. Alagille D., Habib E., Thomassin N. L’atresie des voies biliaires intrahepatiques avec voies biliaires extrahepatiques permeables chez l’enfant. J. Par. Pediatr. 1969;301:301–318. - PubMed
    1. Alagille D., Estrada A., Hadchouel M., Gautler M., Odievre M., Dommergues J. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): Review of 80 cases. J. Pediatr. 1987;110:195–200. doi: 10.1016/S0022-3476(87)80153-1. - DOI - PubMed
    1. Alagille D., Odievre M., Gautier M., Dommergues J. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur. J. Pediatr. 1975;86:63–71. doi: 10.1016/S0022-3476(75)80706-2. - DOI - PubMed
    1. Danks D., Campbell P., Jack I., Rogers J., Smith A. Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch. Dis. Child. 1977;52:360–367. doi: 10.1136/adc.52.5.360. - DOI - PMC - PubMed
    1. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 1997;16:243–251. doi: 10.1038/ng0797-243. - DOI - PubMed

LinkOut - more resources